Editorial: Advances in the treatment of chronic myeloid leukemia

por Eşkazan, Ahmet Emre, Kok, Chung H., Yeung, David, Dalal, Jignesh, Tiribelli, Mario
Publicado 2023

The acquisition order of leukemic drug resistance mutations is directed by the selective fitness associated with each resistance mechanism

por Leow, Benjamin C. S., Kok, Chung H., Yeung, David T., Hughes, Timothy P., White, Deborah L., Eadie, Laura N.
Publicado 2023

Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines

por Kutyna, Monika M., Loone, Sophie, Saunders, Verity A., White, Deborah L., Kok, Chung H., Hiwase, Devendra K.
Publicado 2023

Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib

por Kok, Chung H., Saunders, Verity A., Dang, Phuong, Shanmuganathan, Naranie, White, Deborah, Branford, Susan, Yeung, David, Hughes, Timothy P.
Publicado 2023

p53-Dependent Transcriptional Responses to Interleukin-3 Signaling

por Jabbour, Anissa M., Gordon, Lavinia, Daunt, Carmel P., Green, Benjamin D., Kok, Chung H., D'Andrea, Richard, Ekert, Paul G.
Publicado 2012

Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia

por Irani, Yazad D., Kok, Chung H., Clarson, Jade, Shanmuganathan, Naranie, Branford, Susan, Yeung, David T., Ross, David M., Hughes, Timothy P., Yong, Agnes S. M.
Publicado 2023

Personalized risk model for predicting risk of acute coronary syndrome in patients with myelodysplastic syndromes

por Montarello, Natalie, Leslie, Alasdair, Chhetri, Rakchha, Friel, Oisin, Singhal, Deepak, Ross, David, Yeung, David, Kok, Chung H., Psaltis, Peter J., Hiwase, Devendra K.
Publicado 2023

PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma

por Noll, Jacqueline E., Vandyke, Kate, Hewett, Duncan R., Mrozik, Krzysztof M., Bala, Rachel J., Williams, Sharon A., Kok, Chung H., Zannettino, Andrew CW
Publicado 2015

Integrated Bioinformatics Analysis Reveals Key Candidate Genes and Pathways Associated With Clinical Outcome in Hepatocellular Carcinoma

por Li, Yubin, Chen, Runzhe, Yang, Jian, Mo, Shaowei, Quek, Kelly, Kok, Chung H., Cheng, Xiang-Dong, Tian, Saisai, Zhang, Weidong, Qin, Jiang-Jiang
Publicado 2020

Increased peroxisome proliferator-activated receptor γ activity reduces imatinib uptake and efficacy in chronic myeloid leukemia mononuclear cells

por Wang, Jueqiong, Lu, Liu, Kok, Chung H., Saunders, Verity A., Goyne, Jarrad M., Dang, Phuong, Leclercq, Tamara M., Hughes, Timothy P., White, Deborah L.
Publicado 2017

Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression

por McClure, Barbara J., Heatley, Susan L., Kok, Chung H, Sadras, Teresa, An, Jiyuan, Hughes, Timothy P., Lock, Richard B., Yeung, David, Sutton, Rosemary, White, Deborah L
Publicado 2018

Polycomb Factor PHF19 Controls Cell Growth and Differentiation Toward Erythroid Pathway in Chronic Myeloid Leukemia Cells

por García-Montolio, Marc, Ballaré, Cecilia, Blanco, Enrique, Gutiérrez, Arantxa, Aranda, Sergi, Gómez, Antonio, Kok, Chung H., Yeung, David T., Hughes, Timothy P., Vizán, Pedro, Di Croce, Luciano
Publicado 2021

HoxA9 regulated Bcl-2 expression mediates survival of myeloid progenitors and the severity of HoxA9-dependent leukemia

por Brumatti, Gabriela, Salmanidis, Marika, Kok, Chung H, Bilardi, Rebecca A, Sandow, Jarrod J, Silke, Natasha, Mason, Kylie, Visser, Jolanda, Jabbour, Anissa M, Glaser, Stefan P, Okamoto, Toru, Bouillet, Philippe, D'Andrea, Richard J, Ekert, Paul G
Publicado 2013

A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data

por Sharplin, Kirsty, Proudman, William, Chhetri, Rakchha, Tran, Elizabeth Ngoc Hoa, Choong, Jamie, Kutyna, Monika, Selby, Philip, Sapio, Aidan, Friel, Oisin, Khanna, Shreyas, Singhal, Deepak, Damin, Michelle, Ross, David, Yeung, David, Thomas, Daniel, Kok, Chung H., Hiwase, Devendra
Publicado 2023

Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms

por Shah, Mithun Vinod, Chhetri, Rakchha, Dholakia, Ruchita, Kok, Chung H., Gangat, Naseema, Alkhateeb, Hassan B., Al‐Kali, Aref, Patnaik, Mrinal M., Baranwal, Anmol, Greipp, Patricia T., He, Rong, Begna, Kebede H., Tiong, Ing Soo, Wei, Andrew H., Hiwase, Devendra
Publicado 2022

Heritable GATA2 Mutations Associated with Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia

por Hahn, Christopher N., Chong, Chan-Eng, Carmichael, Catherine L., Wilkins, Ella J., Brautigan, Peter J., Li, Xiao-Chun, Babic, Milena, Lin, Ming, Carmagnac, Amandine, Lee, Young K., Kok, Chung H., Gagliardi, Lucia, Friend, Kathryn L., Ekert, Paul G., Butcher, Carolyn M., Brown, Anna L., Lewis, Ian D., To, L. Bik, Timms, Andrew E., Storek, Jan, Moore, Sarah, Altree, Meryl, Escher, Robert, Bardy, Peter G., Suthers, Graeme K., D’Andrea, Richard J., Horwitz, Marshall S., Scott, Hamish S.
Publicado 2011